Introduction
============

Macroautophagy (hereafter referred to as autophagy) is a cellular degradation system in which cytoplasmic components, including organelles, are sequestered by double membrane structures called autophagosomes and the sequestered materials are degraded by lysosomal hydrolases for supply of amino acids and for cellular homeostasis ([@bib34]; [@bib20]; [@bib24]; [@bib32]). Although autophagy has generally been considered nonselective, recent studies have shed light on another indispensable role for basal autophagy in cellular homeostasis, which is mediated by selective degradation of a specific substrate(s) ([@bib13]; [@bib18]; [@bib12]).

p62 is a ubiquitously expressed cellular protein that is conserved in metazoa but not in plants and fungi, and recently it has been known as one of the selective substrates for autophagy ([@bib1]; [@bib30]; [@bib7]). This protein is localized at the autophagosome formation site ([@bib9]) and directly interacts with LC3, an autophagosome localizing protein ([@bib30]; [@bib7]). Subsequently, the p62 is incorporated into the autophagosome and then degraded ([@bib30]; [@bib7]). Therefore, impaired autophagy is accompanied by accumulation of p62 followed by the formation of p62 and ubiquitinated protein aggregates because of the nature of both self-oligomerization and ubiquitin binding of p62 ([@bib16]; [@bib28]).

The Nrf2--Keap1 system is currently recognized as one of the major cellular defense mechanisms against oxidative and electrophilic stresses. Under quiescent conditions, the transcription factor Nrf2 (nuclear factor erythroid 2--related factor 2) is constitutively degraded through the ubiquitin--proteasome pathway as its binding partner Keap1 (kelch-like ECH-associated protein 1) is an adaptor of the ubiquitin ligase complex. Exposure to electrophiles, reactive oxygen species, and nitric oxide instigates modification of the cysteine residues of Keap1, leading to Keap1 inactivation. Hence, Nrf2 becomes stabilized and translocates to the nucleus to induce the transcription of numerous cytoprotective genes through its heterodimerization with small Maf proteins ([@bib27]; [@bib5]; [@bib43]).

Recently, we and other groups independently reported that p62 interacts with the Nrf2-binding site on Keap1, and thus, overproduction of p62 or autophagy deficiency competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 followed by transcriptional activation of Nrf2 target genes ([@bib2]; [@bib10]; [@bib17]; [@bib19]; [@bib33]). Induction of Nrf2 target genes has been recognized in many human cancers ([@bib5]) that also show p62 accumulation ([@bib46]). However, it is not clear whether p62-induced Nrf2 activation is involved in tumorigenesis and/or tumor progression. In this report, we show that liver-specific *Atg7* knockout mice develop hepatocellular adenoma accompanied by excess accumulation of p62 followed by Nrf2 activation, and that persistent activation of Nrf2 through p62 contributes to development in human hepatocellular carcinoma.

Results and discussion
======================

Loss of *Atg7* in mouse liver causes hepatocellular adenoma
-----------------------------------------------------------

Recently, we found that aged mice with liver-specific *Atg7* deficiency develop multiple tumors in the livers similar to systemically mosaic *Atg5*-deficient mice ([@bib41]), but the exact mechanism of tumorigenesis is still unclear. Thus, we first examined the chronologic changes in the liver-specific *Atg7*-deficient mice (*Atg7^f/f^*;Alb-*Cre*; [@bib16]), including control littermates (*Atg7^f/f^*). Atg7 is an E1-like enzyme for both the Atg12 and Atg8 conjugation systems, and is essential for autophagy ([@bib42]). The mutant mice exhibited severe hepatomegaly with hepatocyte hypertrophy, as reported previously ([@bib15]; [Fig. 1, A and B](#fig1){ref-type="fig"}). Loss of *Atg7* in mouse livers was also accompanied by inflammation, as judged by both hematoxylin and eosin (H&E) staining ([Fig. 1 B](#fig1){ref-type="fig"}) and measuring leakage liver enzymes ([Fig. 1 C](#fig1){ref-type="fig"}). Microtumors (diameter less than ∼1 mm) developed randomly throughout the liver of 7-mo-old mutant mice but not in age-matched control mice ([Fig. 1 A](#fig1){ref-type="fig"}). The number and size of the tumors increased with age, and several tumors in livers of 12-mo-old mutant mice were \>5 mm in diameter ([Fig. 1 A](#fig1){ref-type="fig"} and [Table S1](http://www.jcb.org/cgi/content/full/jcb.201102031/DC1)). H&E staining indicated that the tumors in *Atg7*-deficient livers were in most cases well demarcated with little fibrous capsule, composed of irregular hepatic plates with tumor cells showing large nuclear cytoplasmic ratio and occasional nuclear atypia ([Fig. 1 B](#fig1){ref-type="fig"}). Thus, they were pathologically diagnosed as hepatocellular adenoma.

![**Loss of *Atg7* eventually triggers hepatocellular adenoma.** (A) Chronological changes in gross anatomy of livers of *Atg7^f/f^*;Alb-*Cre* and *Atg7^f/f^* mice. Arrows indicate microtumors. Bars, 1 cm. (B) H&E-stained liver sections of *Atg7^f/f^* and *Atg7^f/f^*;Alb-*Cre* mice aged from 4 to 12 mo. Dashed line: the tumor region in the liver of a representative 12-mo-old *Atg7^f/f^*;Alb-*Cre* mouse. The inset shows higher magnification view of the boxed region containing a mitotic cell (arrowhead). C, central vein; P, portal vein. Bars, 100 µm. (C) Liver function tests of *Atg7^f/f^* (blue bars) and *Atg7^f/f^*;Alb-*Cre* (red bars) mice aged from 4 to 12 mo. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were measured. Data are means ± SD of *Atg7^f/f^* (*n* = 3) and *Atg7^f/f^*;Alb-*Cre* (*n* = 4) at 4 mo of age, of *Atg7^f/f^* (*n* = 3) and *Atg7^f/f^*;Alb-*Cre* (*n* = 3) at 9 mo of age, and of *Atg7^f/f^* (*n* = 5) and *Atg7^f/f^*;Alb-*Cre* (*n* = 5) at 12 mo of age. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. (D) Electron microscopy of nontumor hepatocytes (a and b) and tumor cells (c and d) in *Atg7^f/f^*;Alb-*Cre* mouse liver. The boxed regions in a and c are enlarged and shown as b and d, respectively. The inset in b shows the higher magnification view of a peroxisome (boxed region in b). Note numerous peroxisomes (asterisks) and accumulation of deformed mitochondria (arrowheads) in the peripheral area. Arrows: concentric membranous structures that were consistently present in *Atg7*-deficient hepatocytes. Nu, nucleus; L, lipid droplet. Bars: (a and c) 5 µm; (b and d) 1 µm. (E) Histochemical detection of COX activity in liver sections of *Atg7^f/f^* and *Atg7^f/f^*;Alb-*Cre* mice aged from 4 to 12 mo. Dashed line: liver tumor region in a representative 12-mo-old *Atg7^f/f^*;Alb-*Cre* mouse. Bar, 10 µm. (F) Phospho-histone H2A.X-positive cells in nontumor and tumor regions of 12-mo-old mice of the indicated genotypes. Arrows, cells positive for Phospho-histone H2A.X. Bar, 100 µm.](JCB_201102031_RGB_Fig1){#fig1}

Autophagy deficiency in hepatocytes is accompanied by mitochondria dysfunction and genomic instability
------------------------------------------------------------------------------------------------------

Electron microscopy showed that the phenotype of nontumor regions of *Atg7*-deficient liver of 12-mo-old mice was basically similar to that previously observed in the 3-mo-old *Atg7*-deficient liver ([@bib15]). Specifically, abundance of smooth ER, presence of numerous deformed mitochondria and peroxisomes, and appearance of concentric membranous structures and aggregates were noted ([Fig. 1 D](#fig1){ref-type="fig"}, a and b). Many peroxisomes were as big as the mitochondria and often surrounded by rough ER-derived double-membrane structures ([Fig. 1 D](#fig1){ref-type="fig"}, b). Although the tumor regions showed similar changes, the sections contained larger proportions of deformed mitochondria and scarce concentric membranous structures ([Fig. 1 D](#fig1){ref-type="fig"}, c and d).

To determine whether the deformed mitochondria observed in *Atg7*-deficient hepatocytes and tumor cells are functionally intact, we examined the activity of cytochrome *c* oxidase (COX) enzyme by histochemistry ([@bib8]). As shown in [Fig. 1 E](#fig1){ref-type="fig"}, the activity was markedly reduced by loss of *Atg7* for 4 mo, and the reduction worsened with age. Intriguingly, the hepatocellular adenoma derived from *Atg7*-deficient livers also exhibited reduced COX activity ([Fig. 1 E](#fig1){ref-type="fig"}). These results indicate reduced mitochondrial activity in *Atg7*-deficient hepatocytes and adenoma cells. We also often recognized cells with nuclei positive for phospho-histone H2A.X, representing genomic instability, in both the nontumor and tumor regions of *Atg7*-deficient livers, whereas such cells were not detected in the control tissues at all ([Fig. 1 F](#fig1){ref-type="fig"}). Taken together, it is concluded that autophagy deficiency in mouse livers causes tumorigenesis associated with chronic inflammation, blockade of mitochondrial activity, and genome instability.

Activation of Nrf2 in *Atg7*-deficient tumors
---------------------------------------------

The next series of experiments served to investigate the chronologic changes in the Nrf2--Keap1 pathway in *Atg7*-deficient livers. Immunoblot analysis showed marked accumulation of p62 in livers of 4-mo-old *Atg7^f/f^*;Alb-*Cre* mice, and the presence of both the soluble and insoluble fractions of p62 ([Fig. 2 A](#fig2){ref-type="fig"}). A p62-splicing variant product that migrates faster was also accumulated in both fractions. The quantity of insoluble p62 increased with age, and Keap1 was also fractionated into the insoluble fraction in proportion to the amount of insoluble p62 ([Fig. 2 A](#fig2){ref-type="fig"}). Interestingly, accumulation of p62 was also noted in *Atg7*-deficient tumor regions as well as in the nontumor regions, and significant amounts of p62 and Keap1 were recovered in the insoluble fraction ([Fig. 2 A](#fig2){ref-type="fig"}), implying sequestration of Keap1 into p62 aggregate structures. Indeed, double immunofluorescence microscopy showed that most of the p62-containing aggregates in *Atg7*-deficient nontumor and tumor cells were also positive for Keap1 ([Fig. 2 B](#fig2){ref-type="fig"}). We confirmed not only the induction of gene expression of Nrf2 targets such as *NAD(P)H dehydrogenase quinone 1* (*Nqo1*) and *glutathione S-transferase mu1* (*Gstm1*; [Fig. 2 C](#fig2){ref-type="fig"}), but also increased quantity of Nrf2 and Nqo1 proteins in *Atg7*-deficient livers and tumor region ([Fig. 2 A](#fig2){ref-type="fig"}). Taken together, these results indicate persistent activation of Nrf2 in *Atg7*-deficient tumor regions as well as nontumor regions due to accumulation of p62.

![**Activation of Nrf2 in *Atg7*-deficient hepatocellular adenoma.** (A) Immunoblot analysis. Total, soluble, and insoluble fractions were subjected to SDS-PAGE and analyzed by immunoblotting with the indicated antibodies. Note that the decrease in conversion of LC3-I to LC3-II, which signifies defective autophagosome formation, was confirmed in both the nontumor and tumor regions of the liver of *Atg7*-deficient mice (*Atg7^f/f^*;Alb-*Cre*). Data were obtained from three independent experiments. (B) Immunofluorescence analysis. Liver nontumor or tumor sections from 12-mo-old mice of the indicated genotypes were immunostained with anti-p62 and anti-Keap1 antibodies. The right columns show the merged images of Keap1 (green) and p62 (red). Each inset is a magnified image of the boxed region. Bars, 20 µm. (C) qRT-PCR analysis. Total RNAs were prepared from liver or tumor shown in A. Values were normalized to the amount of mRNA in the *Atg7^f/f^* liver of 4-mo-old (left) and 12-mo-old mice (right). Data are means ± SD of three experiments. \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JCB_201102031_RGB_Fig2){#fig2}

Activation of Nrf2 in human hepatocellular carcinoma
----------------------------------------------------

To investigate whether similar events in *Atg7*-deficient conditions occur in human liver disorders, including hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC), we conducted immunohistochemistry for human liver disease tissue arrays using anti-p62 and anti-Keap1 antibodies. As reported previously ([@bib46]), immunohistochemical analysis with anti-p62 antibody showed abundance of p62 and p62-positive aggregates in several cases of human HCC ([Fig. 3 A](#fig3){ref-type="fig"}). Aggregates positive for Keap1 were also found in the HCC cases that showed p62 aggregates ([Fig. 3 A](#fig3){ref-type="fig"}). As expected, double immunofluorescence microscopy demonstrated extensive colocalization of p62 and Keap1 in numerous aggregates in HCC regardless of the pathological grade ([Fig. 3 B](#fig3){ref-type="fig"}). Quantitative analysis showed that 25.5% (26 of 102 patients) and 21.3% (13 of 61 patients) of HCC and adjacent tissue of HCC contained p62- and Keap1-positive aggregates, respectively ([Table I](#tbl1){ref-type="table"}), albeit the aggregates in the adjacent tissue of HCC tended to be smaller in size and number ([Fig. 3 A](#fig3){ref-type="fig"}). There was no significant correlation between the presence of p62 and Keap1 double-positive aggregates and sex, age of tumor onset, or pathological grade ([Table S2](http://www.jcb.org/cgi/content/full/jcb.201102031/DC1)). These aggregates were also detected in tissues of patients with hepatitis, liver cirrhosis, and non-HCC tumors, though at lower incidence compared with those in HCC and HCC-adjacent tissues ([Table I](#tbl1){ref-type="table"}).

###### 

Presence of Keap1 and p62 double-positive aggregates in human liver diseases.

  Pathological diagnosis                        Total number   p62 and Keap1 double-positive lesions   Percentage
  --------------------------------------------- -------------- --------------------------------------- ------------
  Normal                                        12             0                                       0.0
  Cellular hypertrophy                          2              0                                       0.0
  Hepatitis                                     13             1                                       7.7
  Cirrhosis                                     40             3                                       7.5
  Hepatocellular carcinoma                      102            26                                      25.5
  Tissue adjacent to hepatocellular carcinoma   61             13                                      21.3
  Non-HCC tumor                                 14             1                                       7.1
   Clear cell carcinoma                         5              0                                       --
   Bile duct carcinoma                          4              1                                       --
   Metastasis adenoma                           3              0                                       --
   Sarcoma                                      1              0                                       --
   Hemangioma                                   1              0                                       --

![**Activation of Nrf2 in human HCC containing p62- and Keap1-positive aggregates.** (A) Immunohistochemical images. Paraffin sections of a liver cancer tissue array were stained with anti-p62 or anti-Keap1 antibody. 6 out of 26 HCC cases containing the typical inclusions are shown. Case codes with pathological grade in parenthesis are indicated at the top. Higher magnification views of the boxed regions are shown in the insets. Bars: (panels) 50 µm; (insets) 10 µm. (B) Double immunofluorescence microscopy. Three cases of HCC containing typical inclusions were immunostained with anti-Keap1 and anti-p62 antibodies. The merged images of Keap1 (green) and p62 (red) are shown on the right. Pathological grades are indicated on the left. Bars, 10 µm. (C) qRT-PCR analyses. Total RNAs were prepared from both nontumor and tumor regions of 15 HCCs. Values were normalized to the amount of mRNA in the nontumor region of B6 where p62- and Keap1-positive aggregates were not recognized. Data are means ± SD of three experiments.](JCB_201102031_RGB_Fig3){#fig3}

Is Nrf2 activated in HCC similar to autophagy-deficient tumors? To answer this question, quantitative real-time PCR (qRT-PCR) was conducted with mRNAs prepared from nontumor and tumor regions of HCC patients. The results showed marked induction of *Nqo1*, an Nrf2 target, in 8 out of 15 HCCs positive for p62 and Keap1 aggregates ([Fig. 3 C](#fig3){ref-type="fig"}). These results imply hyperactivation of Nrf2 associated with p62 accumulation in certain types of human HCC.

Nrf2 activation by p62 contributes to tumor growth
--------------------------------------------------

To further clarify the pathological significance of Nrf2 activation in human HCC, we used human HCC cell lines. Among the six human HCC cell lines examined, Huh-1 and JHH-5 cell lines expressed *p62* and *Nqo1* mRNAs and proteins at relatively high levels compared with an immortalized human embryonic kidney cell line, HEK293 ([Fig. 4, A and B](#fig4){ref-type="fig"}). Large amounts of nuclear Nrf2 protein were also found in those two cell lines ([Fig. 4 C](#fig4){ref-type="fig"}). Next, *p62* knockout clones were generated from these two cell lines. The *p62* in both cell lines was successfully deleted using a zinc finger nuclease system comprised of a class of engineered DNA-binding proteins that facilitate targeted editing of the genome by creating double-strand breaks in DNA at specified locations ([@bib23]; [@bib35]). Disruption of *p62* was confirmed by the absence of both *p62* transcript and the protein in *p62*-deficient cell lines (JHH-5\_*p62^−/−^* and Huh-1\_*p62^−/−^*; [Fig. 4, D and E](#fig4){ref-type="fig"}; and unpublished data). Importantly, although p62- and Keap1-positive aggregates were frequently detected in the cytoplasm of both JHH-5 and Huh-1 cell lines, such aggregates were completely dispersed by loss of *p62* ([Fig. 4 F](#fig4){ref-type="fig"}), indicating that like a case in autophagy-deficient tissues ([@bib16]), p62 is responsible for formation of the aggregates.

![**Deletion of *p62* suppressed anchorage-independent growth of human HCC cell line.** (A) qRT-PCR analyses of *p62* and *Nqo1* in HCC cell lines. Values were normalized to the amount of mRNA in Hek293 cells. Data shown are representative of three separate experiments. (B) Immunoblot analysis. Total lysates from the indicated cell lines were subjected to SDS-PAGE and analyzed by immunoblotting with the indicated antibodies. Asterisk indicates a nonspecific band. Data were obtained from three independent experiments. (C) Immunoblot analysis of nuclear Nrf2. Nuclear fractions were prepared from the indicated cell lines, subjected to SDS-PAGE, and analyzed by immunoblotting with antibodies against Nrf2 and lamin B (as control). Data were obtained from three independent experiments. (D) qRT-PCR analysis. Total RNAs were prepared from JHH-5 and JHH-5\_*p62^−/−^* cells. Values were normalized to the amount of mRNA in JHH-5 cells. (E) Immunoblot analysis of p62. Total lysates from JHH-5 and JHH-5\_*p62^−/−^* cells were subjected to SDS-PAGE and analyzed by immunoblotting with p62 and actin antibodies. (F) Double immunofluorescence microscopy. The indicated cell lines were immunostained with anti-p62 and anti-Keap1 antibodies. Bottom row: merged images of p62 (green) and Keap1 (red). Each inset is a magnified image. Bars, 10 µm. (G) qRT-PCR analyses of Nrf2 target genes under three-dimensional (3D) culture conditions. Total RNAs were prepared from JHH5 and JHH-5\_*p62^−/−^* cells under 3D culture condition. Values were normalized to the amount of mRNA in the JHH-5. Data are means ± SD of three experiments. \*\*\*, P \< 0.001. (H) Soft agar colony formation assay. The JHH-5, JHH-5\_*p62^−/−^*, and wild-type p62- or p62 mutant (p62 T350A)--introduced JHH5\_*p62^−/−^* cells were tested for their ability to grow in soft agar. The transformation was determined according to the protocol supplied by the manufacturer. RFU, relative fluorescent unit. Data are means ± SD of three experiments. \*, P \< 0.05; \*\*\*, P \< 0.001.](JCB_201102031_RGB_Fig4){#fig4}

Next, to mimic the physiological environment allowing cells to assemble into the three-dimensional (3D) structures similar to what is observed in vivo, the parent and *p62^−/−^* cell lines were subjected to 3D culture. Because the Huh-1 cell line did not grow in 3D culture conditions, we used the JHH-5 cell line to examine the effect of loss of *p62*. Quantitative analysis showed significant suppression of *Nqo1* and *Gstm1* expression in JHH-5 cells by loss of *p62* under the 3D culture conditions ([Fig. 4 G](#fig4){ref-type="fig"}). Furthermore, the soft agar colony formation assay showed a reduced colony formation in JHH-5\_*p62^−/−^* than parental JHH-5 ([Fig. 4 H](#fig4){ref-type="fig"}), indicating less anchorage-independent growth. As expected, such defect was recovered by forced expression of wild-type p62 but not p62 T350A mutant defective in Keap1 interaction ([@bib17]) into JHH-5\_*p62^−/−^* ([Fig. 4 H](#fig4){ref-type="fig"} and [Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201102031/DC1)). Collectively, these results emphasize the potential role of Nrf2 activation through Keap1 inactivation (by accumulation of p62) in hepatoma development.

Conclusion
----------

Autophagy has become a field of interest for cancer researchers since *Beclin 1*, which is involved in both autophagy and endocytosis ([@bib6]), was reported as a tumor suppressor gene ([@bib21]), and mice heterozygous for this protein developed cancers spontaneously ([@bib31]; [@bib45]). How does autophagy deficiency in mouse livers cause tumorigenesis? Systemically mosaic *Atg5*-deficient mice show accumulation of deformed mitochondria followed by oxidative stress and genome instability in the hepatocytes, culminating in hepatocellular adenoma ([@bib41]). Consistent with this mouse model, we found that loss of *Atg7* in mouse livers was associated with tumorigenesis, which was probably triggered by mitochondrial dysfunction followed by genome instability ([Fig. 1, D--F](#fig1){ref-type="fig"}). In addition to these alterations, chronic inflammation was observed in liver-specific *Atg7*-deficient mice ([Fig. 1, B and C](#fig1){ref-type="fig"}). Thus, it is conceivable that the inflammatory changes also contribute to the tumorigenesis.

Growing lines of evidence indicate that p62 is a scaffold protein for cell survival and death-signaling pathways such as the NF-κB pathway ([@bib36]; [@bib26]; [@bib25]), Wnt signaling ([@bib4]), and apoptosis ([@bib11]). Accordingly, it is plausible that excess p62 leads to dysregulated activation of these signaling pathways. In agreement with this hypothesis, p62 has been identified as a component of inclusion bodies found in various human diseases including HCC and malignant glioma ([@bib46]). Furthermore, the loss of *p62* suppressed Ras-induced lung adenocarcinoma ([@bib3]). Moreover, dysregulation of NF-κB signal in autophagy-incompetent cells was due, at least in part, to accumulation of p62, which subsequently enhanced tumorigenesis ([@bib22]). Those lines of evidence suggest the involvement of aberrant signals related to p62 accumulation in tumorigenesis. We also propose here that persistent activation of Nrf2 through excess accumulation of p62 also contributes to tumor development, as described in the following paragraph.

It has been considered over a long time that marked induction of detoxification enzymes in tumor cells is driven by constant activation of the normal stress response. Recently, somatic mutations in *Keap1* and *Nrf2* were identified in lung, gall bladder, and head and neck tumors ([@bib29]; [@bib40]; [@bib38],[@bib39]). These mutations lead to constitutive activation of Nrf2, followed by induction of Nrf2 target genes, such as cytoprotective enzymes, antioxidant proteins, and multi-drug efflux pumps, thus conferring resistance of tumor cells to oxidative stress and anticancer agents ([@bib39]; [@bib5]). In this regard, the present study showed the presence of p62- and Keap1-positive aggregates and induction of Nrf2 targets in HCC ([Fig. 3](#fig3){ref-type="fig"}). We also noted that cells in areas adjacent to the tumor contained similar aggregates, at an incidence (21.3%) comparable to that of tumor region (25.5%). Both rates were more than threefold that of hepatitis, liver cirrhosis, and non-HCC tumors ([Table I](#tbl1){ref-type="table"}). This implies that accumulation and/or aggregation of p62 and Keap1 could predispose to hepatocarcinogenesis. Importantly, the marked induction of *Nqo1* in tumor regions with massive accumulation of p62 was not associated with increased *p62* mRNA expression ([Fig. 3 C](#fig3){ref-type="fig"}), suggesting that the excess p62 was likely related to the suppression of autophagy. Considering cancers with somatic mutation of *Nrf2* or *Keap1*, some types of HCC with excess levels of p62 would be resistant to oxidative stress and anticancer agents through Nrf2 activation without somatic mutations in *Nrf2* or *Keap1*. Actually, loss of *p62* in human HCC cell line JHH-5 exhibited less anchorage-independent growth than parental cells, and such defect was recovered by forced expression of p62 but not the mutant defective in Keap1 interaction ([Fig. 4 H](#fig4){ref-type="fig"}). These results suggest that continuous activation of Nrf2 through excess accumulation of p62 directly contributes to tumor development. Thus, a better understanding of the cellular fluctuations associated with p62 accumulation and/or failure of autophagy could provide the basis for the development of new therapies for HCC.

Materials and methods
=====================

Mice
----

The *Atg7^f/f^*;Alb-*Cre* mice described previously by our group ([@bib16]) were used in this study. Mice were housed in specific pathogen-free facilities and the experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of the Tokyo Metropolitan Institute of Medical Science and Juntendo University.

Cell culture and gene targeting
-------------------------------

The media and reagents for cell culture were purchased from Life Technologies. HCC cell lines were provided by Health Science Research Resources Bank (Osaka, Japan). Huh-1 and JHH-5 cells were grown in William's E medium containing 10% fetal bovine serum (FBS), 5 U/ml penicillin, and 50 µg/ml streptomycin. The 3D structures were prepared using the AlgiMatrix 3D culture system (Invitrogen). Cells were resuspended, inoculated at 10^6^ cells/well, and then cultured for 7 d. The culture medium was changed every other day. The gene targeting for *p62* of Huh-1 and JHH-5 cells was conducted using the CompoZr Zinc Finger Nuclease (Sigma-Aldrich). Wild-type p62 and p62 T350A mutant were subcloned into retrovirus vector, pMXs-puro ([@bib14]). As described recently ([@bib7]), each p62 and p62 T350A vector was introduced into established JHH-5\_*p62^−/−^* cells.

Immunological analysis
----------------------

Livers were homogenized in 0.25 M sucrose, 10 mM Hepes, pH 7.4, and 1 mM DTT. The resultant homogenates were fractionated into 0.5% Triton X-100 soluble and insoluble fractions. The samples were separated by the NuPage system (Invitrogen) with 12% Bis-Tris gels and MOPS-SDS buffer and transferred to a polyvinylidene difluoride membrane ([@bib17]). The antibodies for p62 (GP62, Progen Biotechnik), Keap1 (Proteintech Group, Inc.), Nqo1 (Abcam), Nrf2 (H-300; Santa Cruz Biotechnology, Inc.), actin (MAB1501R; Millipore), and Lamin B (M-20; Santa Cruz Biotechnology, Inc.) were purchased from the indicated suppliers. The rabbit polyclonal antibodies against Atg7 ([@bib42]) and LC3 ([@bib15]) have been described previously.

Human tissue samples
--------------------

Glass slides with tissue array of various liver diseases were purchased from Shanghai Outdo Biotech Co.; Biochain Institute, Inc.; and Biomax, Inc. Frozen tissues and the corresponding mRNAs were purchased from Shanghai Outdo Biotech Co. This part of the study was approved by the institutional review board of the Tokyo Metropolitan Institute of Medical Science.

Immunofluorescence microscopy
-----------------------------

Cells grown on coverslips were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4, for 15 min, permeabilized with 50 µg/ml digitonin in PB for 5 min, blocked with 0.1% (vol/vol) gelatin (\#G-9391; Sigma-Aldrich) in PB for 30 min, and then incubated with primary antibodies for 1 h. After washing, cells were incubated with Alexa Fluor 488--conjugated goat anti--guinea pig and Alexa Fluor 647--conjugated goat anti--rabbit IgG secondary antibodies (Invitrogen) for 30 min. Cells were imaged using a laser-scanning microscope (LSM510 META; Carl Zeiss, Inc.) with a Plan Apochromat 63x NA 1.4 oil differential interference contrast objective lens. Image contrast and brightness were adjusted using Photoshop CS4 (Adobe).

Histological examination
------------------------

Fixation and embedding procedures for immunohistochemistry were described previously ([@bib44]). In brief, mouse livers were quickly excised, cut into small pieces, and then fixed by immersing in 4% paraformaldehyde/4% sucrose in PB. After rinsing, they were embedded in paraffin for H&E and Keap1 and p62 stainings, or in OCT compound for the staining of phospho-histone H2A.X. As antigen-retrieval procedures, paraffin sections were autoclaved for 10 min at 121°C in buffer at pH 9.0 and 6.0 (Nichirei) for Keap1 and p62 stainings, respectively, whereas cryosections were treated with pepsin solution (Nichirei) for 10 min at 37°C for the staining of phospho-histone H2A.X. Sections were blocked and incubated for 2--3 d at 4°C with the following primary antibodies: guinea pig polyclonal antibody against p62 (Progen), rabbit polyclonal antibody against Keap1 (Proteintech Group), and rabbit monoclonal antibody against phospho-histone H2A.X (Cell Signaling Technology). They were then incubated for 1 h with HRP-conjugated donkey anti--guinea pig IgG (Millipore) or goat anti--rabbit IgG (Histofine simple stain mouse MAX-PO\[R\]; Nichirei) followed by the diaminobenzidine reaction. Double immunofluorescence for p62 and Keap1 was performed using Alexa 549--conjugated goat anti--guinea pig IgG (Invitrogen) and Dylight 488--conjugated donkey anti--rabbit IgG (Jackson ImmunoResearch Laboratories, Inc.), respectively. Cytochrome *c* oxidase (COX) staining was performed as reported previously ([@bib37]; [@bib8]). In brief, air-dried cryosections (10 µm thick) were incubated in reaction medium: 5 mg diaminobenzidine tetrahydrochloride (DAB), 9 ml sodium phosphate buffer (0.05 M, pH 7.4), 1 ml catalase (20 µg/ml), 10 mg cytochrome *c*, and 750 mg sucrose. COX activity was visualized as a brown DAB reaction product.

Images were acquired with a microscope (BX51; Olympus) equipped with a 60x objective lens (PlanApoN, NA 1.42, oil; Olympus) and a cooled CCD camera system (DP-71; Olympus), or a laser-scanning confocal microscope (FV1000; Olympus) with a 60x objective lens (UPlanSApo, NA 1.35, oil; Olympus). After image acquisition, contrast and brightness were adjusted using Photoshop CS4 (Adobe).

Electron microscopy
-------------------

For conventional electron microscopy, small pieces of the liver were fixed by immersing in 2% paraformaldehyde/2% glutaraldehyde in PB, post-fixed with 1% OsO~4~, and embedded in Epon 812 ([@bib44]). After sectioning and staining with uranyl acetate and lead citrate, they were observed under an electron microscope (JEM 1200EX; JEOL).

Quantitative real-time PCR (qRT-PCR)
------------------------------------

Using a Transcriptor First Strand cDNA Synthesis kit (Roche), the cDNA was synthesized from 1 µg of total RNA. Quantitative PCR was performed using LightCycler 480 Probes Master (Roche) in a LightCycler 480 (Roche). Signals were normalized to β-glucuronidase (GUS) for mouse samples and to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for human samples. The sequences of the primers used for mouse samples were: Nqo1F, 5′-AGCGTTCGGTATTACGATCC-3′; Nqo1R, 5′-AGTACAATCAGGGCTCTTCTCG-3′; Gstm1F, 5′-CTACCTTGCCCGAAAGCAC-3′; Gstm1R, 5′-ATGTCTGCACGGATCCTCTC-3′; GusF, 5′-CTCTGGTGGCCTTACCTGA-3′; and GusR, 5′-CTCAGTTGTTGTCACCTTCACC-3′. The sequences of the primers used for human samples were: Nqo1F, 5′-AGCGTTCGGTATTACGATCC-3′; Nqo1R, 5′-AGTACAATCAGGGCTCTTCTCG-3′; Gstm1F, 5′-TGCCCATGATACTGGGGTA-3′; Gstm1R, 5′-GCCACTGGCTTCTGTCATAAT-3′; p62F, 5′-CAGAGAAGCCCATGGACAG-3′; p62R, 5′-AGCTGCCTTGTACCCACATC-3′; GapdhF, 5′-CTCTGGTGGCCTTACCTGA-3′; and GapdhR, 5′-CTCAGTTGTTGTCACCTTCACC-3′.

Transformation in soft agar
---------------------------

Anchorage-independent transformation assays were performed using a CytoSelect 96-well cell transformation assay kit (Cell Biolabs, Inc.). In brief, cells were plated in soft agar in a 96-well plate at 5,000 cells/well and cultured for 5 d. The transformation was determined according to the protocol provided by the manufacturer.

Statistical analysis
--------------------

Values are mean ± SD, including those displayed in the graphs. Statistical analysis was performed using the unpaired *t* test (Welch test). Correlation analyses between p62/Keap1 immunoreactivity and sex and age were performed using the Mann-Whitney test, whereas those among immunoreactivity and histological grades were performed using the Kruskal-Wallis test. A P-value less than 0.05 denoted the presence of a statistical significance.

Online supplemental material
----------------------------

Fig. S1 shows inactivity of the p62 T350A mutant in a Keap1 interaction. Table S1 lists frequency of tumorigenesis in *Atg7*-deficient livers. Table S2 lists proportions of p62 and Keap1 double-positive cases in human liver diseases. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201102031/DC1>.
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